SERPINA3 and breast cancer: We found the SERPINA3 c.918-1G>C variant with a similar frequency in the BC patients and in the controls both in the Helsinki and Tampere BC series and in the FinnGen data; therefore, in the current study, no association with increased BC risk was detected.